09 Feb2015
TrialReach Raises $13.5M Series B To Match Patients To Clinical Trials
TrialReach is an interesting startup on a number of fronts. Firstly, the company is based in London but does most of its business in the “fast-moving” U.S. healthcare market. Secondly, and more significantly, it’s using technology to solve a very human problem and one of the biggest obstacles in medical research: matching the right patients with the right clinical trials, which in turn should help speed up the development of new treatments and ultimately save lives.
